Navigation Links
ROYAL GENIE BLOTTER. (Blots gels up to 20 x 20 cm.

ProductsROYAL GENIE BLOTTER. (Blots gels up to 20 x 20 cm.
Company Idea Scientific
Item ROYAL GENIE BLOTTER. (Blots gels up to 20 x 20 cm.
Features Inquire
Description The GENIE is the proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes for the ultimate in field uniformity. Its design allows for a very close positioning of the electrodes which, when coupled with a low voltage power source such as a battery charger, creates a high field in volts/cm. The result is exceptionally rapid and exact electrophoretic transfer. Blots gels up to 20 x 20 cm. Uses 1.4 liters of buffer. Platinized titanium anode.
Info Idea Scientific
Customer Service: (800) 433-2535
Web site: http://www.ideascientific.com/

Related medicine products :

1. ROYAL™ (Single Use Skin Staplers with Stainless Steel Staples)
2. GENIE BLOTTER
3. MINI-GENIE BLOTTER (Will blot gels up to 10 x 12 c
4. GENIE MONSTER BLOTTER II (Will blot gels up to 30
5. GENIE BLOTTER (Will blot gels up to 15 x 17 cm. Us
6. GENIE POWER SUPPLIES (6 and 12 volt, 1.5 amp output, without timer)
7. GENIE POWER SUPPLIES (6 and 12 volt, 10 amp output, with timer)
8. GENIE POWER SUPPLIES (6, 12, and 24 volt, 10 amp output, without timer)
Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 1Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 1More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 3More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 4More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 5Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 1Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 2Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 3